PRF Technologies Ltd. (PRFX)
Nasdaq: PRFX · Pharmaceutical Preparations · Tel Aviv · filing with the SEC since 2020
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
| Report filed | Mar 26, 2026 | Apr 7, 2025 | Feb 29, 2024 | Mar 15, 2023 | Mar 16, 2022 | Mar 18, 2021 | · | · |
| Revenue | 17 | 0 | 0 | · | · | · | · | · |
| For lenders | ||||||||
| Net interest income | · | · | · | 0 | 0 | -987 | · | · |
| Cost of revenue | 70 | 0 | 0 | · | · | · | · | · |
| Research and development | 1,136 | 11,705 | 6,035 | 4,422 | 2,860 | 354 | 136 | 223 |
| Selling, general and administrative | 1,402 | 1,322 | 1,676 | 2,091 | 2,155 | · | · | · |
| Sales and marketing | 163 | 0 | 0 | · | · | · | · | · |
| General and administrative | 3,011 | 2,968 | 3,549 | 4,447 | 4,348 | 1,317 | 553 | 277 |
| Operating income | -5,122 | -14,673 | -9,584 | -8,869 | -7,208 | -1,671 | -689 | -500 |
| Interest expense | · | · | · | · | · | 271 | 379 | 324 |
| Interest and investment income | · | · | · | 160 | 0 | 0 | · | · |
| Total non-operating income (expense) | 108 | 93 | 248 | 86 | -32 | -1,175r | -590 | -328 |
| Income before income taxes | -5,014 | -14,580 | -9,336 | -8,783 | -7,240 | -3,833 | -1,279 | -828 |
| Income tax expense | 8 | 8 | 8 | 9 | 6 | 220 | 0 | · |
| Net income | -5,022 | -14,588 | -9,344 | -8,792 | -7,246 | -4,053 | -1,279 | -828 |
| Net income to common shareholders | · | · | · | · | -7,246 | -4,053 | -2,409 | -1,874 |
| Earnings per share, basic | -7.47 | -105.52r | -122.94r | -63.46r | -7.25r | -12.2669b | · | · |
| Earnings per share, diluted | -7.47 | -105.52r | -122.94r | -63.46r | -7.25r | -12.2669b | · | · |
| Earnings per share, basic and diluted | · | · | · | · | -7.262b | -12.2669b | -40.9225b | -31.7959b |
| Weighted average shares, basic | 647,973 | 138,254r | 76,005r | 138,548r | 999,562r | 330,558b | · | · |
| Weighted average shares, diluted | 647,973 | 138,254r | 76,005r | 138,548r | 999,562r | 330,558b | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | 999,867b | 330,558b | 58,751b | 58,751b |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the change of share basis.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesNet interest income interest earned less interest paid
us-gaap:InterestIncomeExpenseNetCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfRevenueResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseSales and marketing the cost of finding and serving customers
us-gaap:SellingAndMarketingExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseDebtInterest and investment income what its cash and investments earned
us-gaap:InterestIncomeOtherTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted